Carbonic anhydrase inhibitors and their therapeutic potential | 2000/05/01 | English | 447 |
Antiglaucoma carbonic anhydrase inhibitors: a patent review | 2013/04/30 | English | 249 |
Applications of carbonic anhydrase inhibitors and activators in therapy | 2002/02/01 | English | 228 |
Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013) | 2013/03/14 | English | 223 |
Anticancer carbonic anhydrase inhibitors: a patent review (2008 – 2013) | 2013/05/15 | English | 220 |
Antiobesity carbonic anhydrase inhibitors: a literature and patent review | 2013/04/22 | English | 216 |
Schiff bases in medicinal chemistry: a patent review (2010-2015) | 2016/11/07 | English | 207 |
Silver and its application as an antimicrobial agent | 2005/02/01 | English | 204 |
Sulfonamides: a patent review (2008 – 2012) | 2012/06/15 | English | 195 |
Anti-infective carbonic anhydrase inhibitors: a patent and literature review | 2013/03/14 | English | 186 |
Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016) | 2018/02/05 | English | 158 |
Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review | 2013/03/21 | English | 157 |
Solid lipid nanoparticles: a review on recent perspectives and patents | 2020/01/31 | English | 155 |
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018) | 2018/08/09 | English | 154 |
5-Lipoxygenase inhibitors: a review of recent developments and patents | 2010/02/24 | English | 147 |
Recent advances in therapeutic chalcones | 2004/12/01 | English | 146 |
Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review | 2011/04/04 | English | 143 |
Therapeutic effects of EGCG: a patent review | 2016/06/29 | English | 142 |
Carbonic anhydrase inhibitors and activators and their use in therapy | 2006/11/22 | English | 142 |
Piperazine derivatives for therapeutic use: a patent review (2010-present) | 2016/05/31 | English | 141 |
Coumarin-based drugs: a patent review (2008 – present) | 2012/04/01 | English | 141 |
Modulation of carbonic anhydrase activity and its applications in therapy | 2004/05/01 | English | 138 |
Recent developments in CCR2 antagonists | 2009/03/01 | English | 138 |
Deuterated drugs: where are we now? | 2014/07/29 | English | 136 |
Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity | 2003/10/01 | English | 132 |
The development of novel therapies for rheumatoid arthritis | 2008/06/19 | English | 128 |
Taxane anticancer agents: a patent perspective | 2015/12/10 | English | 127 |
GPR119 agonists for the treatment of type 2 diabetes | 2009/09/28 | English | 125 |
Novel sulphonamide derivatives for the treatment of cancer | 2000/11/01 | English | 121 |
Betulinic acid and its derivatives: a patent review (2008 – 2013) | 2014/06/07 | English | 120 |